These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32658605)

  • 1. Rational optimization of a monoclonal antibody improves the aggregation propensity and enhances the CMC properties along the entire pharmaceutical process chain.
    Bauer J; Mathias S; Kube S; Otte K; Garidel P; Gamer M; Blech M; Fischer S; Karow-Zwick AR
    MAbs; 2020; 12(1):1787121. PubMed ID: 32658605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
    Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
    MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the impact of amino acid substitution in a monoclonal antibody on cation exchange chromatography.
    Saleh D; Hess R; Ahlers-Hesse M; Beckert N; Schönberger M; Rischawy F; Wang G; Bauer J; Blech M; Kluters S; Studts J; Hubbuch J
    Biotechnol Bioeng; 2021 Aug; 118(8):2923-2933. PubMed ID: 33871060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model-directed engineering of "difficult-to-express" monoclonal antibody production by Chinese hamster ovary cells.
    Pybus LP; Dean G; West NR; Smith A; Daramola O; Field R; Wilkinson SJ; James DC
    Biotechnol Bioeng; 2014 Feb; 111(2):372-85. PubMed ID: 24081924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in silico assessment of the developability of a designed monoclonal antibody library.
    Wolf Pérez AM; Sormanni P; Andersen JS; Sakhnini LI; Rodriguez-Leon I; Bjelke JR; Gajhede AJ; De Maria L; Otzen DE; Vendruscolo M; Lorenzen N
    MAbs; 2019; 11(2):388-400. PubMed ID: 30523762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pragmatic mAb lead molecule engineering from a developability perspective.
    Chi B; De Oliveira G; Gallagher T; Mitchell L; Knightley L; Gonzalez CC; Russell S; Germaschewski V; Pearce C; Sellick CA
    Biotechnol Bioeng; 2021 Oct; 118(10):3733-3743. PubMed ID: 33913507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.
    Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R
    Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systemic approach to identifying sequence frameworks that decrease mAb production in a transient Chinese hamster ovary cell expression system.
    Szkodny AC; Lee KH
    Biotechnol Prog; 2024; 40(5):e3466. PubMed ID: 38607316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trace levels of the CHO host cell protease cathepsin D caused particle formation in a monoclonal antibody product.
    Bee JS; Tie L; Johnson D; Dimitrova MN; Jusino KC; Afdahl CD
    Biotechnol Prog; 2015; 31(5):1360-9. PubMed ID: 26259961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
    Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
    J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boosting antibody developability through rational sequence optimization.
    Seeliger D; Schulz P; Litzenburger T; Spitz J; Hoerer S; Blech M; Enenkel B; Studts JM; Garidel P; Karow AR
    MAbs; 2015; 7(3):505-15. PubMed ID: 25759214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational optimization of a monoclonal antibody for simultaneous improvements in its solution properties and biological activity.
    Kumar S; Roffi K; Tomar DS; Cirelli D; Luksha N; Meyer D; Mitchell J; Allen MJ; Li L
    Protein Eng Des Sel; 2018 Jul; 31(7-8):313-325. PubMed ID: 30189027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving monoclonal antibody selection and engineering using measurements of colloidal protein interactions.
    Geng SB; Cheung JK; Narasimhan C; Shameem M; Tessier PM
    J Pharm Sci; 2014 Nov; 103(11):3356-3363. PubMed ID: 25209466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.
    Chng J; Wang T; Nian R; Lau A; Hoi KM; Ho SC; Gagnon P; Bi X; Yang Y
    MAbs; 2015; 7(2):403-12. PubMed ID: 25621616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Russell body phenotype is preferentially induced by IgG mAb clones with high intrinsic condensation propensity: relations between the biosynthetic events in the ER and solution behaviors in vitro.
    Hasegawa H; Woods CE; Kinderman F; He F; Lim AC
    MAbs; 2014; 6(6):1518-32. PubMed ID: 25484054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of unintended amino acid sequence changes in recombinant monoclonal antibodies expressed in Chinese Hamster Ovary (CHO) cells.
    Guo D; Gao A; Michels DA; Feeney L; Eng M; Chan B; Laird MW; Zhang B; Yu XC; Joly J; Snedecor B; Shen A
    Biotechnol Bioeng; 2010 Sep; 107(1):163-71. PubMed ID: 20506532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A general evidence-based sequence variant control limit for recombinant therapeutic protein development.
    Zhang A; Chen Z; Li M; Qiu H; Lawrence S; Bak H; Li N
    MAbs; 2020; 12(1):1791399. PubMed ID: 32744138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer-mediated flocculation of transient CHO cultures as a simple, high throughput method to facilitate antibody discovery.
    Schmitt MG; Rajendra Y; Hougland MD; Boyles JS; Barnard GC
    Biotechnol Prog; 2017 Sep; 33(5):1393-1400. PubMed ID: 28722325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique Impacts of Methionine Oxidation, Tryptophan Oxidation, and Asparagine Deamidation on Antibody Stability and Aggregation.
    Alam ME; Slaney TR; Wu L; Das TK; Kar S; Barnett GV; Leone A; Tessier PM
    J Pharm Sci; 2020 Jan; 109(1):656-669. PubMed ID: 31678251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of process conditions influencing protein aggregation in Chinese hamster ovary cell culture.
    Paul AJ; Handrick R; Ebert S; Hesse F
    Biotechnol Bioeng; 2018 May; 115(5):1173-1185. PubMed ID: 29280480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.